Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLFS NASDAQ:INMD NASDAQ:LIVN NASDAQ:OM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$27.68-0.6%$25.84$19.10▼$29.55$1.33B1.95465,410 shs177,792 shsINMDInMode$16.01$14.97$13.14▼$19.85$1.01B2.091.19 million shs454,031 shsLIVNLivaNova$54.71+1.1%$54.47$32.48▼$58.91$2.99B0.95669,840 shs367,512 shsOMOutset Medical$15.27-1.7%$13.97$5.85▼$25.35$271.35M2.13225,075 shs360,777 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions+1.98%+1.60%+8.96%+30.13%+17.90%INMDInMode+4.57%+4.64%+8.91%+11.10%-9.96%LIVNLivaNova+0.69%+4.48%-1.64%+24.20%+0.99%OMOutset Medical+17.21%+23.16%+9.52%-18.05%+77.89%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$27.68-0.6%$25.84$19.10▼$29.55$1.33B1.95465,410 shs177,792 shsINMDInMode$16.01$14.97$13.14▼$19.85$1.01B2.091.19 million shs454,031 shsLIVNLivaNova$54.71+1.1%$54.47$32.48▼$58.91$2.99B0.95669,840 shs367,512 shsOMOutset Medical$15.27-1.7%$13.97$5.85▼$25.35$271.35M2.13225,075 shs360,777 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions+1.98%+1.60%+8.96%+30.13%+17.90%INMDInMode+4.57%+4.64%+8.91%+11.10%-9.96%LIVNLivaNova+0.69%+4.48%-1.64%+24.20%+0.99%OMOutset Medical+17.21%+23.16%+9.52%-18.05%+77.89%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLFSBioLife Solutions 2.67Moderate Buy$31.2913.03% UpsideINMDInMode 2.00Hold$16.855.25% UpsideLIVNLivaNova 2.50Moderate Buy$59.719.15% UpsideOMOutset Medical 2.50Moderate Buy$24.6761.54% UpsideCurrent Analyst Ratings BreakdownLatest LIVN, OM, INMD, and BLFS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/10/2025INMDInModeCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$14.00 ➝ $16.0010/10/2025INMDInModeNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold10/8/2025BLFSBioLife SolutionsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025INMDInModeWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/8/2025LIVNLivaNovaWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025OMOutset MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/7/2025BLFSBioLife SolutionsZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold10/1/2025LIVNLivaNovaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy ➝ Neutral$55.0010/1/2025LIVNLivaNovaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$55.009/29/2025INMDInModeZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold9/27/2025BLFSBioLife SolutionsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLFSBioLife Solutions$93.47M14.19$0.12 per share223.00$7.52 per share3.68INMDInMode$401.56M2.52$1.91 per share8.39$10.12 per share1.58LIVNLivaNova$1.25B2.38$4.32 per share12.67$24.31 per share2.25OMOutset Medical$113.69M2.39N/AN/A$7.49 per share2.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLFSBioLife Solutions-$20.18M-$0.12N/AN/AN/A-5.39%0.16%0.14%11/11/2025 (Estimated)INMDInMode$181.27M$2.476.488.80N/A44.50%18.38%16.35%11/5/2025 (Estimated)LIVNLivaNova$63.23M-$3.89N/A17.42N/A-16.13%14.57%6.91%11/5/2025 (Estimated)OMOutset Medical-$127.98M-$20.29N/A∞N/A-82.06%-97.17%-32.84%11/5/2025 (Estimated)Latest LIVN, OM, INMD, and BLFS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/11/2025Q3 2025BLFSBioLife Solutions-$0.01N/AN/AN/A$25.69 millionN/A11/5/2025Q3 2025INMDInMode$0.32N/AN/AN/A$88.05 millionN/A11/5/2025Q3 2025LIVNLivaNova$0.91N/AN/AN/A$342.32 millionN/A11/5/2025Q3 2025OMOutset Medical-$0.64N/AN/AN/A$30.69 millionN/A8/7/2025Q2 2025BLFSBioLife Solutions-$0.02-$0.33-$0.31-$0.33$23.71 million$25.42 million8/6/2025Q2 2025LIVNLivaNova$0.84$1.05+$0.21$0.50$332.20 million$352.50 million7/30/2025Q2 2025INMDInMode$0.50$0.47-$0.03$0.42$98.45 million$95.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLFSBioLife SolutionsN/AN/AN/AN/AN/AINMDInModeN/AN/AN/AN/AN/ALIVNLivaNovaN/AN/AN/AN/AN/AOMOutset MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLFSBioLife SolutionsN/A4.433.45INMDInModeN/A9.608.58LIVNLivaNova0.311.291.09OMOutset Medical0.637.476.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLFSBioLife Solutions93.24%INMDInMode68.04%LIVNLivaNova97.64%OMOutset MedicalN/AInsider OwnershipCompanyInsider OwnershipBLFSBioLife Solutions2.20%INMDInMode6.92%LIVNLivaNova0.29%OMOutset Medical2.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLFSBioLife Solutions44047.91 million46.85 millionOptionableINMDInMode48063.21 million58.84 millionOptionableLIVNLivaNova2,90054.60 million54.44 millionOptionableOMOutset Medical52017.77 million17.34 millionNot OptionableLIVN, OM, INMD, and BLFS HeadlinesRecent News About These CompaniesOutset Medical (NASDAQ:OM) Trading Up 6.1% - Here's What HappenedOctober 15, 2025 | marketbeat.comReviewing Outset Medical (NASDAQ:OM) & PPJ Enterprise (OTCMKTS:PPJE)October 13, 2025 | americanbankingnews.comOutset Medical's (OM) Sell (D-) Rating Reaffirmed at Weiss RatingsOctober 10, 2025 | marketbeat.comOutset Medical: Revenue Trajectory Yet To Reflect Favorable Demand TailwindsSeptember 22, 2025 | seekingalpha.comOutset Medical, Inc. (OM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comOUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmSeptember 4, 2025 | globenewswire.comOutset Medical announces collaboration Northwest Kidney CentersSeptember 3, 2025 | msn.comNorthwest Kidney Centers Partners with Outset Medical to Enhance Home Hemodialysis Access with Tablo SystemSeptember 3, 2025 | quiverquant.comQNorthwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home HemodialysisSeptember 3, 2025 | globenewswire.comOutset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare ConferenceAugust 20, 2025 | globenewswire.comOutset Medical’s Earnings Call Highlights Strong GrowthAugust 15, 2025 | theglobeandmail.comOutset Medical (OM) Receives a Hold from OppenheimerAugust 15, 2025 | theglobeandmail.comOutset Medical Inc.August 15, 2025 | barrons.comAfter Plunging 26.8% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical (OM)August 15, 2025 | zacks.comWhat To Expect From Outset Medical Inc (OM) Q2 2025 EarningsAugust 7, 2025 | finance.yahoo.comOutset Medical Reports Strong Q2 Growth and Raises GuidanceAugust 7, 2025 | msn.comOutset Medical, Inc. (OM) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comOutset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue EstimatesAugust 6, 2025 | zacks.comOutset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and UtilizationAugust 6, 2025 | globenewswire.comUncovering Potential: Outset Medical's Earnings PreviewAugust 5, 2025 | benzinga.comOutset Medical Appoints Brittni McGill as Chief Nursing Officer to Enhance Dialysis Care InnovationJuly 30, 2025 | quiverquant.comQNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesDatavault AI: The New AI Contender Backed by Big FundingBy Jeffrey Neal Johnson | October 1, 20253 Quantum Computing ETFs to Know—And Why 2 Don't Hold D-WaveBy Nathan Reiff | September 23, 2025Top 3 Dividend Achievers for October: High Yields, Growth AheadBy Thomas Hughes | October 1, 2025Downgraded But Not Done: 3 Stocks Ready for a Market ComebackBy Thomas Hughes | September 24, 2025When Downgrades Create Opportunities: 3 Stocks to Watch NowBy Thomas Hughes | October 7, 2025LIVN, OM, INMD, and BLFS Company DescriptionsBioLife Solutions NASDAQ:BLFS$27.68 -0.18 (-0.65%) Closing price 04:00 PM EasternExtended Trading$27.72 +0.04 (+0.13%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.InMode NASDAQ:INMD$16.01 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$15.98 -0.04 (-0.22%) As of 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.LivaNova NASDAQ:LIVN$54.71 +0.61 (+1.13%) Closing price 04:00 PM EasternExtended Trading$54.72 +0.01 (+0.01%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.Outset Medical NASDAQ:OM$15.27 -0.26 (-1.67%) Closing price 04:00 PM EasternExtended Trading$15.28 +0.01 (+0.07%) As of 05:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Micron Stock Could Soar 35% on AI Memory Demand WesBanco Insiders Signal Confidence With Coordinated Buys Will D-Wave's European Expansion Keep Fueling the Rally? Navitas Soars 78% on NVIDIA Update: Is This Rally Sustainable? Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet Waymo’s Global Expansion Strengthens the Case for GOOGL Stock Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Meta vs OpenAI: Is Sora a True Threat to Meta's Dominance? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
